Latest news
Loading news…
iECURE
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Blue Bell, Pennsylvania, United States Founded 2020 11-50 employees For Profit
iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
24
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- IT spend
- $50K
Company Info
- Founded
- 2020
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 51
- HQ
- Blue Bell, Pennsylvania, United States
- Region
- Greater Philadelphia Area, Great Lakes, Northeastern US
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- -0.3
- Trend (30d)
- -1.3
- Trend (90d)
- -1.1
- Last leadership hire
- Apr 25, 2022
Key People at iECURE
Chief Executive Officer & Boar Member
VP Head of Technical Operations
Vice President, Therapeutic Area Lead, Urea Cycle Disorders
24
professional contacts at iECURE
Contact execs at iECURE →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to iECURE
Loading news…
FAQs about iECURE
People who checked this page also checked these
Browse the full Acquirezy directory.